News

Dentsply Sirona Inc. Faces Class Action Lawsuit: Key Updates

Dentsply Sirona Inc. Faces Class Action Lawsuit: Key Updates

Class Action Lawsuit Overview Against Dentsply Sirona Inc.

The Gross Law Firm is notifying shareholders about an important class action lawsuit involving Dentsply Sirona Inc. (NASDAQ: XRAY), emphasizing the rights and potential claims of investors. The firm invites shareholders who acquired shares during a specific period to connect and explore their roles in this legal matter.

Details of the Class Period and Allegations

Defining the Class Period

The class period for this lawsuit extends from December 1, 2022 to November 6, 2024, encompassing significant events and corporate actions affecting Dentsply Sirona and its market operations. Shareholders during this timeframe may have legal recourse due to the unfolding circumstances.

Key Allegations Against Dentsply

The allegations suggest numerous missteps and omissions by Dentsply Sirona's management. They reportedly targeted low-income populations lacking access to proper dental care, which prompted patients with potential underlying issues to engage with Byte, a DTC aligner solution. Concerns arose about the sales strategies employed, as employees allegedly pushed for sales without adequate checks, adhering to questionable practices.

Consequences of Alleged Misconduct

As reports of patient injuries associated with Byte surfaced, troubling patterns emerged. The company was accused of neglecting its obligation to notify the FDA regarding serious damage claims, a significant oversight considering the potential risks involved with its dental products. The legal claims detail a troubling narrative where Dentsply's statements regarding the efficacy and safety of their aligners were allegedly misleading.

Strategies for Affected Shareholders

Steps to Take

Shareholders are urged to register their information promptly to ensure they are positioned to participate in the resolution process while keeping abreast of pivotal updates related to their claims. The final date to express interest in becoming a lead plaintiff is set for January 27, 2025. Engaging in this class action carries no financial obligations for participants.

Monitoring Progress

By registering, shareholders will gain access to portfolio monitoring services, providing ongoing updates about the progression of the lawsuit and their investment status. This initiative serves to empower investors affected by the alleged malpractice and ensure they remain informed and involved throughout the case.

Why Choose The Gross Law Firm?

The Gross Law Firm stands as a respected advocate for investors, committed to holding corporations accountable for unethical practices. With a mission focused on protecting investor rights, the firm actively pursues justice for those impacted by misleading statements and illicit actions that inflate stock values fraudulently. Their dedication encompasses not just legal representation but also a higher standard of corporate integrity among businesses.

Contact Information for Dentsply Shareholders

Dentsply shareholders seeking more information or assistance can easily reach out to the Gross Law Firm. Here are the details to contact them:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903

Frequently Asked Questions

What is the class action lawsuit against Dentsply Sirona Inc. about?

The class action lawsuit focuses on allegations that Dentsply failed to disclose critical safety issues regarding its Byte products, resulting in significant patient injuries.

How can I participate in the class action?

Shareholders who purchased shares during the specified class period can register for updates and potentially seek lead plaintiff status before the deadline.

What is the deadline for filing?

The final date to consider becoming a lead plaintiff in the lawsuit is set for January 27, 2025.

What support does the Gross Law Firm provide?

The Gross Law Firm offers portfolio monitoring services and regular updates to registered shareholders about the lawsuit's progress and status.

Is there a cost to participate in the lawsuit?

No, there are no costs or obligations for shareholders to participate in this class action lawsuit.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Mitsubishi CEO Chikumoto Wins 2026 Palladium Medal

Updated Category News Views 30

Here's something to tip your hat to: Manabu Chikumoto, the head honcho of Mitsubishi Chemical Group, snagged the 2026 International Palladium Medal. You don't get this one by just sitting pretty behind a desk. The folks at the Société de Chimie Industrielle—the ones responsible for this prestigious accolade—know a thing or two about setting high bars in the chemical...

Continue Reading
ACR Poker's $20M OSS: Stakes High on Sunday Action

Updated Category News Views 89

ACR Poker Takes the Spotlight with a Mammoth Sunday Sunday, November 15 is about to be a slugfest over at ACR Poker, as players gear up for an intense day of card-shuffling and betting. We’re looking at flights for all four headlining events of the Online Super Series (OSS) right alongside day two of The Quattro and an eye-popping WSOP Paradise Mega Satellite blowing...

Continue Reading
Choosing Screen-Free Outdoor Gifts: besrey's Top Picks

Updated Category News Views 24

The Art of Choosing Outdoor Gifts for Kids Christmas time, my friends, isn't just about plastic gimmicks and gadgets vying for kids' attention. Nope, it's about making thoughtful decisions that blend discovery, movement, and a little peace of mind for parents. This time around, besrey's got the scoop on screen-free gifts that might just do the trick—helping kids explore...

Continue Reading
Decoding Arrest: Steps from Arraignment to Trial

Updated Category News Views 43

Someone lands in handcuffs, and it's the start of a winding road through the justice system. We're talking about the stages you gotta navigate, explained by Criminal Law Attorney Tangi Carter. If you're anywhere near Hattiesburg, Mississippi, or quite frankly, have any eye on legal matters in your backyard, you know having a roadmap is pure gold. Arraignment: The...

Continue Reading
Emergency Strobe Light Device Eyes Market Potential

Updated Category News Views 10

An Idea Sparked in San Marcos This ain't your typical cocktail party chat. We're diving into a story born from necessity—where someone's trying to shave seconds off a life-or-death situation. From the busy streets of San Marcos, California, an inventor has brought a practical gem to the table: the LIFE STROBE. This gizmo is not just a bulb with a new flash pattern. It's...

Continue Reading
Anderson University Sees Financial Turnaround Success

Updated Category News Views 13

Anderson University, against all odds, is shaking up the financial narrative they’ve been stuck in for a while. It’s kind of like finding a $20 bill in an old coat—a nice surprise but it doesn’t happen every day. The university’s recent report on their financial progress is reminding folks that when it comes to fiscal discipline, sometimes you just need fresh...

Continue Reading
Palatin Prepares for FY27 Results Amid Market Curiosity

Updated Category News Views 5

Mark Your Calendars, Investors! Folks grumble about the mundane task of checking fiscal calendars, but without this intel, where are we? On November 17, 2026, Palatin Technologies (NASDAQ:PTN) is slated to release their Q1 Fiscal Year 2027 operating results bright and early, before most of us have even sipped our coffee. The buzz around these numbers is as electric as any...

Continue Reading
Aethlon's Merger Moves: High Stakes and High Hopes

Updated Category News Views 129

Two-Step Merger Raises Eyebrows It's not every day you see a company like Aethlon Medical, Inc. (NASDAQ: AEMD) shake up its core operations with a bold merger move. On September 17, 2026, Aethlon signed off on a Plan of Merger and Reorganization with North Immunology, Inc.—a clear signal to investors that the winds of change are blowing strong. Implications of the...

Continue Reading
AST SpaceMobile Faces Class Action Suit Deadline Looms

Updated Category News Views 56

AST SpaceMobile's Securities Class Action: The Lowdown When you roll the dice on a company like AST SpaceMobile, Inc. (NASDAQ: ASTS), you want to believe that you're betting on the stars. But lately, some investors might feel like they're seeing more darkness than starlight. Here's the kicker: AST SpaceMobile is staring down a securities fraud class action lawsuit. It's a...

Continue Reading
FDA Greenlights AI for Brain Aneurysm Detection

Updated Category News Views 105

Unveiling UPTUNITY: A New AI Solution Well, ain't that something? Bracco and Avicenna.AI just got the FDA's nod for their latest creation, UPTUNITY. It's like giving radiologists a trusty sidekick to spot those sneaky brain aneurysms. This ain't just another gizmo; it's a game-changer in medical imaging, giving AI a real shot at transforming how these medical sleuths do...

Continue Reading

Top 5 Most Recently Viewed Articles

Ascletis Advances ASC47 with Encouraging Phase Ib Study Results

Updated Category News Views 313

Exciting Developments in ASC47 Research Ascletis Pharma Inc. is making significant strides in the realm of obesity treatment with its promising candidate, ASC47. This innovative drug is designed to be an adipose-targeted, muscle-preserving solution aimed at tackling obesity. Recent Phase Ib studies have provided compelling pharmacokinetic data and weight loss outcomes,...

Continue Reading
USAA Federal Savings Bank Ordered to Improve Safety Practices

Updated Category News Views 279

USAA Federal Savings Bank Faces Regulatory Scrutiny The U.S. Office of the Comptroller of the Currency (OCC) has recently directed USAA Federal Savings Bank to rectify several regulatory deficiencies classified as unsafe. These issues, which the bank has grappled with for a number of years, reflect gaps in management practices, earnings strategies, information technology...

Continue Reading
RoosterBio and Thermo Fisher Team Up for Advanced Cell Therapies

Updated Category News Views 379

RoosterBio and Thermo Fisher: A Game-Changing Collaboration RoosterBio, Inc., a prominent supplier of adult human mesenchymal stem/stromal cells (hMSCs), has announced a strategic collaboration with Thermo Fisher Scientific. This partnership aims to enhance the manufacturing processes for groundbreaking cell and exosome therapies, promising to make significant advances in...

Continue Reading
Nvidia's Datacenter Revenue Anticipations for Q4 Set to Surge

Updated Category News Views 136

Nvidia's Positive Outlook for Datacenter Revenues in Q4 Analysts from Bernstein are feeling optimistic about Nvidia’s (NASDAQ: NVDA) datacenter revenues as the fourth quarter approaches. Their analysis indicates that we can anticipate a significant rise in revenue, driven by recent advancements in Nvidia's product lineup. Insights from Recent Discussions After a...

Continue Reading
Impact of Financial Status on Longevity Among Older Adults

Updated Category News Views 194

Understanding Longevity Disparities Among Older Adults A recent analysis has revealed a stark reality concerning older adults and their financial stability. Research indicates that those earning $20,000 or less annually tend to die on average nine years earlier than individuals earning $120,000 or more. This significant disparity highlights the urgent need to address the...

Continue Reading